# Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia

> **NCT00554840** · PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 16 (actual)

## Conditions studied

- Cigarette Smoking
- Schizophrenia

## Interventions

- **DRUG:** varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00554840
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554840, "Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00554840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*